Barron\'s - 30.09.2019

(singke) #1

September 30, 2019 BARRON’S M7


The Striking Price


Options


Betting on a Netflix Bounceback


By Steven M. Sears


THINKING OF TRADING ON PRESIDENT DONALD


Trump’simpeachmentinquiry?You’reprob-


ably better off focusing on more knowable


dramas—suchas Netflix ’sdefanginginthe


stock market.


The streaming-media giant has fallen


from favor after leading the stock market


higher for many years, along with other


FAANG stocks including Facebook (FB),


Apple (AAPL), Amazon.com (AMZN),and


Alphabet (GOOGL).


Netflix stock (ticker: NFLX) slipped


intonegativeterritoryfortheyearonMon-


day. Shares are down about 2% in 2019,


about 32% below their May high, and off


some 30% over the past year.


Investors fear major competition from


Apple’sand WaltDisney ’s(DIS)streaming


services, both of which should launch in


November. And every bump in Netflix’s


businessincreasesitsfearpremiuminthe


options market.


Netflix remains a key way that younger


peoplewatchTV.Thus,themostimportant


question becomes how successful Netflix’s


new competitors will be in attracting new


customers.Agoodbet,andoneatoddswith


thestatusquoview,isthatmanypeoplewill


terminatetheircablesubscriptionsandbuy


allthreestreamingservices,especiallyifthe


originalcontentisascompellingasNetflix’s


Orange Is the New Black and Narcos.


Investors seem to miss that people buy


contentarguablymorethanchannels,andit


ishardtofinanciallyvaluecreativity.Ifthat


holdsinanewer,morecompetitiveenviron-


ment, the real issue for streaming services


will be which produces the best content.


Butit’shardforanalyststocreatemod-


els that measure ideas that cannot be ex-


pressedinnumbers.It’sfareasiertobear-


ishly adjust Netflix’s models—especially


sincesubscribergrowthhasweakened—than


totellclientstoholdsteadybecausestream-


ing content is about to get interesting.


Of course, this more positive view will


taketimetoplayout—liketheimpeachment


inquiry—buttheweaknessinNetflix’sstock


isarealopportunityforanyonecomfortable


selling cash-secured put options to buy the


stock below its 52-week low.


WithNetflixstockaround$263,investors


canselltheDecember$240putfor$11.50.If


thestockremainsabovetheputstrikeprice,


investors keep the hefty put premium.


Should the stock be below $240 at expira-


tion,investorsmusteitherbuythestockat


thestrikeprice,althoughtheeffectivepur-


chase price would be $228.50 (strike price


minuspremium),orcovertheput.(Putsin-


crease in value when stock prices decline.)


Over the past 52 weeks, Netflix’s stock has


ranged from $231.23 to $386.80.


The Netflix fear premium is high. J.P.


Morgan’s Shawn Quigg is telling clients


thatNetflix’soptionsarehistoricallyexpen-


sive.Thespreadbetweenthree-monthim-


plied volatility and realized volatility is at


the78thpercentileoverthattime,anindi-


cation that the options market is pricing


the stock as under pressure and likely to


make a big move.


The December expiration covers Net-


flix’s third-quarter earnings on Oct. 16. A


keytraderiskisthatsomethingspooksin-


vestors in the earnings report, all of the


fears about the future suddenly congeal,


and it causes a selling stampede.


Shouldthatoccur,investorscouldmake


upthedeclinebysellingcallsorputswith


strike prices above or below the stock


price.Netflixisexpectedtoreportfourth-


quarterearningsonJan.16,sotheimplied


volatility of those options will probably


quickly reflect November’s earnings.


If Netflix’s management team is savvy,


the company will, in the interim, manage


investor sentiment by releasing original


content,orbyannouncingplanstorelease


original content, that will compete well


against Apple and Disney.


After all, as all good executives know,


content is king. The suggested trade


expresses faith in Netflix’s long-term com-


petitiveness and a belief that the market


mob is always too bullish or too bearish.


That always creates opportunities for cold-


eyed investors who have the time and


resources to take advantage of them.


Equity Options


CBOE VOLATILITY INDEX


VIX Close VIX Futures

10


15


20


25


30


35


40


NDJ FMAM J J A S

Daily Values Source: CBOE

THE EQUITY-ONLY PUT-CALL RATIO


Put-Call Ratio S&P 500 Index

50


85


120


155


190


225


260


O NDJ FMAM J J A S

Source: McMillan Analysis Corp.

SPX SKEW


Implied volatility %

8


9


10


11


12


13%


O NDJ FMAM J J A S

Source: Credit Suisse Equity Derivatives Strategy

NDX SKEW


Implied volatility %

8


9


10


11


12%


O NDJ FMAM J J A S

Source: Credit Suisse Equity Derivatives Strategy

Skew indicates whether the options market expects a stock-market advance or decline. It measures the difference
between the implied volatility of puts and calls that are 10% out of the money and expire in three months. Higher
readings are bearish.

Week'sMostActive


Company Symbol TotVol Calls Puts AvgTotVol IV%ile Ratio

AAR Corp AIR 4619 3730 889 388 82 11.9


Synnex SNX 11916 7296 4620 1080 58 11.0


Comtech Telecom CMTL 2572 1284 1288 260 1 9.9


BRF-Brasil Foods BRFS 13248 12893 355 1368 50 9.7


Akcea Therapeutics AKCA 3226 1036 2190 400 49 8.1


Dova Pharm DOVA 4390 3762 628 548 56 8.0


FactSet FDS 9074 2688 6386 1156 93 7.8


Kforce KFRC 2079 1968 111 272 53 7.6


Nike NKE 495877 278405 217472 65508 49 7.6


Commercial Metals CMC 6400 4530 1870 976 97 6.6


Nucor NUE 83432 56398 27034 15052 84 5.5


Diamond Offshore DO 26642 2707 23935 4912 99 5.4


Jabil Circuit JBL 37659 23045 14614 7164 70 5.3


Entergy ETR 8187 6608 1579 1632 75 5.0


PriceSmart PSMT 6150 2292 3858 1244 91 4.9


BlackBerry BB 193474 118433 75041 40608 81 4.8


Virtu Financial VIRT 12548 10628 1920 2660 73 4.7


SMART Global Holdings SGH 3691 1173 2518 788 91 4.7


Cintas CTAS 7431 4244 3187 1608 33 4.6


Marathon Petroleum MPC 288123 229064 59059 64524 90 4.5


Thistableofthemostactiveoptionsthisweek,ascomparedto average weeklyactivity–notjustrawvolume.Theideaisthatthe
unusuallyheavytradingintheseoptionsmightbeapredictorofcorporateactivity–takeovers,earningssurprises,earningspre-
announcements,biotechFDAhearingsordrugtrialresultannouncements,andsoforth.Dividendarbitragehasbeeneliminated.In
short,thislistattemptstoidentifywhereheavyspeculationistakingplace. Theseoptionsarelikelytobeexpensiveincomparisonto
theirusualpricinglevels.Furthermore,manyofthesesituationsmayberumor-driven.Mostrumorsdonotprovetobetrue,soone
shouldbeawareoftheseincreasedrisksiftradinginthesenames
RatioistheTotVoldividedbyAvgTotVol.IV%ileishowexpensivetheoptionsareonascalefrom0to100.

Source:McMillanAnalysis

Free download pdf